How many insider declarations has Avat Xavier filed?

Avat Xavier has filed 3 public insider declarations with SEC (Form 4).

What is Avat Xavier's role?

Avat Xavier's reported role is not specified by the regulator across the filings.

Which companies does Avat Xavier report trades for?

Avat Xavier reports trades for Capricor Therapeutics, INC..

What is Avat Xavier's declared buy vs sell volume?

Across the available history, declared buys total 5k€ and disposals 868.8M€.

← Executives ★ Sign in to follow

AX

Avat Xavier

·SEC (Form 4)

Capricor Therapeutics, INC.

累计流向

0

申报总数

0

公司

€5,402

▲ 买入（1 笔）

€9亿

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

2

T+90 胜率

100%

T+90 平均收益

+20.6%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Discover the detailed record of transactions filed by Avat Xavier. Insider active across 1 company, notably Capricor Therapeutics, INC.. Aggregated, 3 filings have been published. Breakdown: 1 buy · 2 sells. Total volume traded: €868.8m. History available since 29 June 2022. The latest transaction was disclosed on 17 April 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.

Companies and markets linked to Avat Xavier

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Capricor Therapeutics, INC. (US)

申报3 总计

▼

Avat Xavier

高管2023年4月17日Capricor Therapeutics, INC.

US$9亿12SEC ↗

14,772 股@ US$64,258.00100.0% 占其流量Common StockSEC:0001931345-23-000003:0

▼

Avat Xavier

高管2023年3月28日Capricor Therapeutics, INC.

US$12,1804SEC ↗

3,000 股@ US$4.060.0% 占其流量Common StockSEC:0001415889-23-006365:0

▲

Avat Xavier

CHIEF BUSINESS OFFICER高管2022年6月29日Capricor Therapeutics, INC.

US$5,64315SEC ↗

1,500 股@ US$3.76190.0% 占其流量Common StockSEC:0001415889-22-007544:0

标准退出：2022年9月27日 (T+90)

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

AX

Avat Xavier

·SEC (Form 4)

Capricor Therapeutics, INC.

累计流向

0

申报总数

0

公司

€5,402

▲ 买入（1 笔）

€9亿

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

2

T+90 胜率

100%

T+90 平均收益

+20.6%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

Discover the detailed record of transactions filed by Avat Xavier. Insider active across 1 company, notably Capricor Therapeutics, INC.. Aggregated, 3 filings have been published. Breakdown: 1 buy · 2 sells. Total volume traded: €868.8m. History available since 29 June 2022. The latest transaction was disclosed on 17 April 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.